Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

3.6K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
3.6K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

209
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
209
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

322
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
322
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

4.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduction of Cerebrospinal Fluid Leaks in Idiopathic Intracranial Hypertension with Glucagon-like Peptide-1 Receptor Agonist Use.

Journal of neurological surgery. Part B, Skull base·2026
Same author

Validity and Responsiveness of Chronic Rhinosinusitis Control Test Subdomains.

The Laryngoscope·2026
Same author

Translation and Cross-Cultural Adaptation of the Chronic Rhinosinusitis Control Test for Global Use.

International forum of allergy & rhinology·2026
Same author

Recognizing and Addressing Treatable Traits in Patients With Chronic Rhinosinusitis With Nasal Polyposis: Can We Do Better?

The journal of allergy and clinical immunology. In practice·2026
Same author

Disease Remission: A Scoping Review With Thematic Analysis of the Scientific Literature With Implications for Chronic Rhinosinusitis.

International forum of allergy & rhinology·2026
Same author

Psychometric Validation of the Overall Symptom Severity Score for Chronic Rhinosinusitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026

Related Experiment Video

Updated: Aug 12, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

586

Defining 'control' of chronic rhinosinusitis.

Ahmad R Sedaghat1, Katie M Phillips

  • 1Department of Otolaryngology - Head & Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Current Opinion in Otolaryngology & Head and Neck Surgery
|February 2, 2023
PubMed
Summary

Assessing chronic rhinosinusitis (CRS) control reveals a gap between patient and provider perspectives. Future criteria should integrate both viewpoints for standardized CRS treatment.

More Related Videos

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

1.9K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.5K

Related Experiment Videos

Last Updated: Aug 12, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

586
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

1.9K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.5K

Area of Science:

  • Otolaryngology
  • Immunology
  • Clinical Medicine

Background:

  • Chronic rhinosinusitis (CRS) is a prevalent condition lacking a cure, making disease control a primary treatment objective.
  • Defining and assessing CRS control is crucial for guiding therapeutic strategies and managing patient outcomes.
  • Existing recommendations for CRS control assessment vary, necessitating a review of their alignment with patient and healthcare provider (HCP) perspectives.

Approach:

  • This review synthesizes current recommendations for assessing CRS control.
  • It specifically examines how these recommendations align with the perspectives of both patients experiencing CRS and the HCPs managing their care.
  • The analysis focuses on identifying discrepancies and commonalities in the understanding and assessment of disease control.

Key Points:

  • Several staging systems for CRS control exist, with the 2012 European Position Paper on Rhinosinusitis and Nasal Polyps being a prominent example.
  • A significant divergence is observed between patients' and HCPs'/guideline-based assessments of CRS control.
  • Patients prioritize perceived severity of nasal symptoms, while HCPs consider a broader range of factors including nasal and extra-nasal symptoms, and medication use.

Conclusions:

  • Current methods for assessing CRS control do not fully reconcile patient and provider viewpoints.
  • Further research is needed to develop consensus-based criteria that incorporate both perspectives.
  • A standardized approach to CRS treatment may be achieved through future development of control criteria reflecting shared understanding between patients and HCPs.